advertisement
Doumazos L 14
Showing records 1 to 14 |
Display all abstracts from Doumazos L111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyKandarakis SA
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&reKandarakis S
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyPetrou P
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&rePapadopoulos AP; Roussopoulos G
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyDoumazos S
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&reGeorgopoulos E
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyChronopoulou K
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&reChung Y
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyDoumazos L
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&reDoumazos L
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyHalkiadakis I
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&reBaek A
Expert Opinion on Drug Safety 2023; 0: 1-12
111991 Combining Perfluorobutylpentane (FH) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot StudyGeorgalas I
Turkish journal of ophthalmology 2023; 53: 281-288
112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&rePaizi NI; Shin H; Papadopoulos PA
Expert Opinion on Drug Safety 2023; 0: 1-12